Hikma Pharmaceuticals PLC/ GB00B0LCW083 /
2024-03-28 5:29:48 PM | Chg. +48.00 | Volume | Bid5:30:00 PM | Ask5:30:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
1,924.50GBX | +2.56% | 68,285 Turnover(GBP): 1.31 mill. |
-Bid Size: - | -Ask Size: - | 4.25 bill.GBP | - | - |
GlobeNewswire
2021-02-25
Amarin Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
GlobeNewswire
2021-01-26
Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insu...
GlobeNewswire
2020-01-09
Arecor and Hikma Announce Exclusive Agreement to Develop and Commercialise Ready-To-Use Medicine Usi...
GlobeNewswire
2019-06-03
Gout Therapeutic Market is projected to reach US$ 3820 Million by 2027- TMR